CEO, President, Cofounder @Seismic_Tx | Supporter of #womeninstem @WESTorg and #communityphilanthropy @LS_Cares | Devoted dance mom | Fan of live theater
Boston, MA
Joined October 2011
- Tweets576
- Following282
- Followers510
- Likes1.2K
Jo Viney (she/her) retweeted
Today our CBO Maude Tessier will discuss BD/M&A deal valuations at the 20th Convergence Forum @CONVFORUM, bringing together high-level healthcare players to discuss and debate the most pressing life sciences topics. #CVFORUM23 #SeismonautsInAction
Jo Viney (she/her) retweeted
We're looking forward to sharing our progress at IMMUNOLOGY 2023, with 2 oral presentations and 7 posters on Ig-sculpting enzymes and dual-cell bidirectional #antibody programs to control dysregulated adaptive immunity. #AAI2023.
seismictx.com/seismic-therap…
Jo Viney (she/her) retweeted
This unique & stimulating session provided tricks & tips on how we can enhance scientific & executive storytelling by considering posture and emotion, through the creative arts. Powerful arias combined with practical tips - Opera & the Art of Corporate Communication @LabCentral !
Jo Viney (she/her) retweeted
Our team gathered for an interactive lunch & learn session on Neurodiversity where we discussed valuing differences and building a more inclusive workplace culture. Thank you to Aspire for this informative event! #SeismonautsInAction
massgeneral.org/children/asp…
Jo Viney (she/her) retweeted
Jyothsna, Seismic Director, Drug Creation, is a panelist this week discussing career changes and growth in R&D and drug discovery, hosted by WEST – Women in the Enterprise of Science and Technology @WESTorg. #SeismonautsInAction
Jo Viney (she/her) retweeted
Jeffrey Ravetch MD PhD, an expert in receptors that bind Fc region of antibodies & Seismic Founder, describes Fc receptors in immunology & insights for Seismic’s novel Dual Cell Bidirectional antibodies in a Q&A with our BD Associate, Rebecca Goydel PhD
seismictx.com/founder-qa-wit…
Jo Viney (she/her) retweeted
“Creativity taking the possible and turning the ordinary into the extraordinary” #events @LabCentral !
Please do join us!
labcentral.site/opera
Coming soon to @LabCentral: a unique event exploring the connections between Opera performance & the art of corporate communication. Whether you are a CEO making an investor pitch, a scientist communicating a new concept, or simply someone who regularly uses their voice in their profession, a powerful speaking voice can prove to be an asset!
Learn more and register: labcentral.site/opera
Jo Viney (she/her) retweeted
Coming soon to @LabCentral: a unique event exploring the connections between Opera performance & the art of corporate communication. Whether you are a CEO making an investor pitch, a scientist communicating a new concept, or simply someone who regularly uses their voice in their profession, a powerful speaking voice can prove to be an asset!
Learn more and register: labcentral.site/opera
Jo Viney (she/her) retweeted
5th Emerging Frontiers in Oncology is May 18, 2023 at MassBio Hub in Kendall Sq. This years theme is timely: Back to Basics – the Gap in Translation
All proceeds go to Life Science Cares Boston. Register HERE: emergingfrontiersoncology.co…
Jo Viney (she/her) retweeted
Can #opera help your corporate communication skills?Join @LabCentral & @Seismic_Tx for a stimulating session on how to enhance your scientific & #executive #storytelling by considering #posture #emotion. Inc - one step masterclass & live performance. bit.ly/3lG193M
Jo Viney (she/her) retweeted
We're pleased to welcome our new Chief People Officer, Melanie Manning, with more than 20 years of experience as an executive HR leader! We look forward to collaborating to support our growth and commitment to an uplifting, inclusive culture. #WeAreSeismic
Jo Viney (she/her) retweeted
We're thrilled to be named the Emerging Company of the Year in Life Sciences at the #NEVYs22 Awards, presented at last night's outstanding event. Thank you to @NewEnglandVC and to all Seismonauts for their hard work. Congratulations to all nominees and winners. #WeAreSeismic
Jo Viney (she/her) retweeted
Urjana, Program Manager, R&D at Seismic, shared her Albanian culture, hosting a tasting table of food, sweets and drinks at @LabCentral's Cultural Celebration this week. #SeismonautsInAction
Jo Viney (she/her) retweeted
Our CBO Maude Tessier will moderate a discussion with David Jenkins (VP, Head of External Innovation at Ipsen) at the 4th CENE (Canadian Entrepreneurs in New England) Catalyst Forum, discussing the trials and tribulations of dealmaking in biopharma.
thecene.org/catalystforum202…
Jo Viney (she/her) retweeted
Nathan Higginson-Scott, PhD, our Chief Technology Officer and SVP, Drug Creation, presented today on Seismic and applying machine learning to immunology drug development at the 14th Annual PEGS Europe (Protein and Antibody Engineering Summit). #PEGSEurope
pegsummiteurope.com/optimisa…
Jo Viney (she/her) retweeted
Tomorrow, our Chief Medical Officer and Head of R&D John Sundy, PhD, will be part of a panel discussing academic/industry relationships and how to best engage at the ACR Convergence meeting in Philadelphia. #ACR2022
rheumatology.org/Annual-Meet…
Jo Viney (she/her) retweeted
From entrepreneurship to elevating women leaders, our CEO Jo Viney @76viney discusses highlights and challenges in this @BosBizJournal profile as a 2022 honoree of the BBJ's Women Who Lead in Life Sciences.
bizjournals.com/boston/news/…
Jo Viney (she/her) retweeted
Check out this @BosBizJournal interview with @76viney, CEO, President, and Cofounder of @Seismic_Tx: bizjournals.com/boston/news/…
Jo Viney (she/her) retweeted
We love to lift up Seismonauts making a difference, as recognized by their co-workers. Lindsey, our lab manager, made our move to new Lab Central space smooth and seamless. Thanks, Lindsey!
Jo Viney (she/her) retweeted
Very excited to celebrate the opening of @LabCentral 238 w/ @MassLtGov yesterday — a first-of-its-kind #lab and scale-up #biomanufacturing space for 10+ #biotech companies and 200+ employees funded by @MALifeSciences, which will be critical to getting new treatments to patients.
